<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-140665" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Trichodysplasia spinulosa</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Moore</surname>
            <given-names>Marlyn J.</given-names>
          </name>
          <aff>Uniformed Services University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Rampton</surname>
            <given-names>Robert</given-names>
          </name>
          <aff>Midwestern University, Glendale, AZ</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Marlyn Moore declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Robert Rampton declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>3</day>
          <month>5</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-140665.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Trichodysplasia spinulosa is a rare dermatologic condition characterized by painless erythematous papules on the face with folliculocentric keratin spines. This condition is unique to patients with trichodysplasia spinulosa-associated polyomavirus (TSPyV) in the setting of immunosuppression. The comparatively low incidence of trichodysplasia spinulosa within the susceptible population does not align with the ubiquitous nature of TSPyV in the general population, implying an insufficient understanding of this condition. This activity reviews the evaluation and proposed treatment of trichodysplasia spinulosa and highlights the role of the interprofessional team in identifying patients with this condition to improve patient care.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the epidemiology of trichodysplasia spinulosa.</p></list-item><list-item><p>Review the clinical presentation of trichodysplasia spinulosa.</p></list-item><list-item><p>Identify the diagnostic findings and histopathologic features of trichodysplasia spinulosa.</p></list-item><list-item><p>Summarize the role of the interprofessional healthcare team in recognition, work-up, and treatment of this condition.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=140665&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=140665">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-140665.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Trichodysplasia spinulosa is a rare dermatologic condition characterized by painless erythematous papules on the face with folliculocentric keratin spines. This condition is unique to patients with trichodysplasia spinulosa-associated polyomavirus (TSPyV) in the setting of immunosuppression.<xref ref-type="bibr" rid="article-140665.r1">[1]</xref>&#x000a0;</p>
        <p>The first report of this condition was in 1995, described as a disseminated follicular spiny hyperkeratosis, thought to be a side effect of cyclosporin.<xref ref-type="bibr" rid="article-140665.r2">[2]</xref>&#x000a0;</p>
        <p>Subsequent case reports clarified that an immunosuppressed state, as opposed to cyclosporin specifically, is the common thread between patients with this condition. In 1999, trichodysplasia spinulosa was formally named as such with the discovery of its viral etiology, which in 2010 was characterized as a novel polyomavirus and aptly named trichodysplasia spinulosa-associated polyomavirus.<xref ref-type="bibr" rid="article-140665.r3">[3]</xref><xref ref-type="bibr" rid="article-140665.r4">[4]</xref>&#x000a0;Ongoing recognition and reporting of trichodysplasia spinulosa in the medical literature are needed to better understand and treat this condition.</p>
      </sec>
      <sec id="article-140665.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Trichodysplasia spinulosa-associated polyomavirus (TSPyV) is classified under the&#x000a0;family: <italic toggle="yes">Polyomaviridae, g</italic>enus: A<italic toggle="yes">lphapolyomavirus, </italic>and species: <italic toggle="yes">Human polyomavirus 8.</italic></p>
        <p>Polyomaviruses are about 45 nanometers in size, with an icosahedral capsid enclosing a circular, double-stranded DNA genome.<xref ref-type="bibr" rid="article-140665.r5">[5]</xref>&#x000a0;The name &#x0201c;polyomavirus&#x0201d; is derived from the prefix <italic toggle="yes">poly</italic>, meaning multiple, and the suffix <italic toggle="yes">oma</italic>, meaning tumor, based on the ability of certain polyomaviruses to induce tumor formation in immunocompromised animals.<xref ref-type="bibr" rid="article-140665.r6">[6]</xref></p>
        <p>Human polyomaviruses are ubiquitous in the human population but typically asymptomatic.<xref ref-type="bibr" rid="article-140665.r5">[5]</xref>&#x000a0;Proposed mechanisms for trichodysplasia spinulosa in the context of immunosuppression include primary TSPyV infection, re-exposure to TSPyV, or reactivation of latent TSPyV similar to other well-known human polyomaviruses, JC virus, and BK virus.<xref ref-type="bibr" rid="article-140665.r7">[7]</xref>&#x000a0;The discordance between the high seroprevalence of TSPyV and the low number of reported cases of trichodysplasia spinulosa in the susceptible population implies other etiologic factors at play that have yet to be elucidated.</p>
      </sec>
      <sec id="article-140665.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Although trichodysplasia spinulosa as a clinical entity is predominantly documented in patients with compromised immune systems, infection with the causative virus is widespread. Serologic studies of individuals both with and without compromised immune systems indicate that the prevalence of TSPyV is between 65-80% in both populations.&#x000a0;TSPyV has no apparent gender predilection, but seroprevalence differences between age groups implicate that primary infection occurs during childhood.<xref ref-type="bibr" rid="article-140665.r8">[8]</xref></p>
        <p>Due to the rarity of this condition and the limited number of case reports, there is insufficient data to establish valid patterns of geographic distribution. Presumably, as this condition becomes more widely recognized and more frequently reported, geographic patterns may align with the distribution of immunocompromised populations.</p>
        <p>Risk factors for trichodysplasia spinulosa include solid organ transplant, immunosuppressive medications, hematolymphoid malignancy, and HIV infection. All but one of the reported cases thus far have occurred in patients with indisputable immune compromise.</p>
        <p>In September 2014, a case of trichodysplasia spinulosa was reported in a man with Gorlin syndrome being treated for multiple basal cell carcinomas with vismodegib. His trichodysplasia spinulosa eruption was reportedly painful, which is atypical, and resolved when vismodegib was discontinued. No historical or laboratory evidence of immunodeficiency was found.<xref ref-type="bibr" rid="article-140665.r9">[9]</xref>&#x000a0;Outliers aside, the majority of trichodysplasia spinulosa cases in the literature involve patients with solid organ transplants or leukemia.</p>
      </sec>
      <sec id="article-140665.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The genomes of <italic toggle="yes">Polyomaviridae</italic> are divided into three main regions: the non-coding control region, the early gene region, and the late gene region. The non-coding control region, as the name implies, does not encode any genes to be transcribed but is responsible for the regulation of gene expression. The early gene region encodes proteins (large tumor antigen and small tumor antigen) that disrupt cell cycle control and enable viral genome replication utilizing host replication machinery. The late gene region encodes structural proteins (VP1, VP2, and VP3) that form the viral capsid and facilitate host cell attachment. Additional TSPyV proteins have been identified, but their functions remain unclear.<xref ref-type="bibr" rid="article-140665.r10">[10]</xref>&#x000a0;Other features of the polyomavirus genome include alternative splicing to allow multiple proteins to be encoded within a single transcript and the utilization of host cell histones to add structure and resilience to viral DNA.<xref ref-type="bibr" rid="article-140665.r6">[6]</xref></p>
        <p>Serologic studies of TSPyV antibodies over time suggest that newborns initially have maternally sourced antibodies that wane over the following months. Throughout childhood, TSPyV transmission likely occurs between family members due to close interpersonal contact.<xref ref-type="bibr" rid="article-140665.r11">[11]</xref>&#x000a0;The precise route or mechanism of transmission of TSPyV is not yet known, nor is the duration of latent infection or preferred cellular reservoir. Aside from the skin, TSPyV has been detected in several different tissue types and bodily locations with unclear clinical relevance as there is no indication of TSPyV causing any other disease. Potential reservoir sites include the conjunctiva, nasopharynx, tonsils, upper respiratory tract, heart, gastrointestinal tract, cerebrospinal fluid, urine, and stool.</p>
        <p>Hypotheses about the potential pathophysiology of trichodysplasia spinulosa are as follows: symptomatic reactivation of latent TSPyV due to immunosuppression, repeat exposure to TSPyV while immunosuppressed, and fulminant primary infection with TSPyV while immunosuppressed.<xref ref-type="bibr" rid="article-140665.r12">[12]</xref>&#x000a0;</p>
        <p>As stated previously, there are likely unidentified variables besides immunosuppression and viral infection which influence the mechanism of disease. At the cellular level, one possible difference between asymptomatic and symptomatic TSPyV infection could be the route of intracellular viral transmission. The lytic pathway for intracellular viral transmission is a highly inflammatory process, whereas non-lytic transmission utilizing extracellular vesicles is more covert and, in fact, anti-inflammatory due to phosphatidylserine lipids on the vesicle surface.<xref ref-type="bibr" rid="article-140665.r13">[13]</xref>&#x000a0;</p>
        <p>Although not specifically demonstrated with TSPyV, other polyomaviruses (BKPyV and JCPyV) have been shown to infect target cells by way of extracellular vesicles. Therefore, it is possible that other polyomaviruses harness this ability as well.<xref ref-type="bibr" rid="article-140665.r14">[14]</xref>&#x000a0;</p>
        <p>Regardless of the mechanism by which this typically sub-clinical virus becomes pathogenic, once such conditions are met, inner root sheath follicular keratinocytes appear to be the primary target of TSPyV. Interactions with tumor suppressor genes pRB, p16, p21, and protein phosphatase 2 lead to hyperproliferation of the inner root sheath, presumably producing the characteristic follicular spines.<xref ref-type="bibr" rid="article-140665.r15">[15]</xref><xref ref-type="bibr" rid="article-140665.r16">[16]</xref>&#x000a0;</p>
        <p>The absence of dermal papillae in affected skin explains the associated alopecia because papillae are essential for new hair growth. For this same reason, the mechanism by which the papillae are lost must be reversible because hair regrows after the condition resolves.<xref ref-type="bibr" rid="article-140665.r17">[17]</xref><xref ref-type="bibr" rid="article-140665.r18">[18]</xref>&#x000a0;Ultimately, further research is needed to fully understand and define the pathophysiology of trichodysplasia spinulosa.</p>
      </sec>
      <sec id="article-140665.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Key histologic features include dilated hair follicles, keratin plugging, abundant dystrophic and cornfield inner root sheath epithelium, and numerous, large eosinophilic trichohyalin granules within the inner root sheath cells.&#x000a0;</p>
        <p>Other features include apoptotic cells, epidermal acanthosis and may include mild perifollicular lymphocytic inflammation.<xref ref-type="bibr" rid="article-140665.r3">[3]</xref><xref ref-type="bibr" rid="article-140665.r5">[5]</xref>&#x000a0;Hair shafts and papilla are notably absent.<xref ref-type="bibr" rid="article-140665.r17">[17]</xref></p>
        <p>The inner root sheath epithelial cells stain with Ki-67, indicative of hyperproliferation, and&#x000a0;toluidine blue, which reflects increased nucleic acids from dysplastic cells.<xref ref-type="bibr" rid="article-140665.r5">[5]</xref><xref ref-type="bibr" rid="article-140665.r19">[19]</xref> The abundance of viral DNA in affected tissue may also contribute to toluidine blue staining based on its affinity for nucleic acids. Still, this extrapolation is not corroborated by dermatopathology texts, potentially due in part to the rarity of this condition.</p>
      </sec>
      <sec id="article-140665.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Patients with trichodysplasia spinulosa present with a papular, follicular facial rash with spiny keratosis, referred to as &#x0201c;spicules,&#x0201d; and non-scarring alopecia of the eyebrows. The lesions are often asymptomatic but may be somewhat pruritic. As lesions coalesce and the skin thickens, facial features can become distorted and cause a leonine facial appearance. Papules may be flesh-colored, erythematous, or hyperpigmented. The central face is most frequently affected, but other areas such as the ears, trunk, and arms may also be involved.<xref ref-type="bibr" rid="article-140665.r3">[3]</xref><xref ref-type="bibr" rid="article-140665.r17">[17]</xref></p>
        <p>Immunosuppression is a critical historical component, whether it is due to medications, organ transplant, cancer, or HIV. Most reported cases involve patients with solid organ transplants on anti-rejection medications or patients being treated for hematolymphoid malignancy.</p>
      </sec>
      <sec id="article-140665.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>In addition to histopathological examination of a skin biopsy, diagnostic tools for trichodysplasia spinulosa may include polymerase chain reaction or electron microscopy. Serologic tests are not necessary to establish the diagnosis of trichodysplasia spinulosa. Still, they may be indicated if an underlying immune-compromising condition has not previously been identified for any patient presenting with trichodysplasia spinulosa.</p>
        <p><bold>Polymerase chain reaction</bold>: PCR is considered the &#x0201c;gold standard&#x0201d; diagnostic test for trichodysplasia spinulosa when used in concert with clinical observation and histology. Utilizing a tissue sample of the affected skin or spicules removed from the affected skin, quantitative PCR demonstrates high copy numbers of the TSPyV genome. Low copy numbers and samples from unaffected areas are not diagnostically useful as TSPyV has been identified in various tissues types, stated previously, to include individuals with no clinical evidence of trichodysplasia spinulosa.<xref ref-type="bibr" rid="article-140665.r5">[5]</xref></p>
        <p><bold>Electron microscopy</bold>: On transmission electron microscopy, the affected tissue will have intranuclear clusters of icosahedral viral inclusions with a &#x0201c;bumpy&#x0201d; appearance, around 40 nanometers in size.<xref ref-type="bibr" rid="article-140665.r3">[3]</xref><xref ref-type="bibr" rid="article-140665.r17">[17]</xref></p>
        <p><bold>Serology</bold>: For diagnostic purposes, serology does not have significant utility based on the ubiquitous nature of this virus, as discussed previously.&#x000a0;However, given the clear correlation between compromised immunity and this condition, any patient without a prior diagnosis should undergo a thorough history and physical. Further testing for immunodeficiency should be guided by clinical judgment but may include a complete blood count, HIV test, peripheral blood smear, or antibody titers.</p>
      </sec>
      <sec id="article-140665.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Several treatments for trichodysplasia spinulosa have been attempted, but a widely accepted treatment plan still evades the medical community. The three seemingly most effective approaches include topical cidofovir, oral valganciclovir, and reduction of immunosuppression.&#x000a0;</p>
        <p>Topical cidofovir 3% has been recommended as a first-line treatment for trichodysplasia spinulosa based on a trend of treatment success in case reports. Topical cidofovir as a possible treatment is further supported by in vitro evidence that cidofovir inhibits human polyomavirus replication. Oral valganciclovir has also been effective in several cases and is more accessible than topical cidofovir but lacks the evidentiary support of in vitro or in vivo studies showing activity against human polyomavirus. Regarding reducing immunosuppressive therapy, the risk of sub-therapeutic dosing, transplant rejection, and progression or relapse of underlying disease often outweighs the benefit of reversing trichodysplasia spinulosa.</p>
        <p>Various other topical treatments have been tried with inconsistent efficacy, such as leflunomide, topical retinoids, steroids, imiquimod, keratolytics, emollients, green tea extract, and other anti-virals.<xref ref-type="bibr" rid="article-140665.r1">[1]</xref></p>
      </sec>
      <sec id="article-140665.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Histopathology and polymerase chain reaction can be used to definitively diagnose trichodysplasia spinulosa and rule out the other clinically similar conditions listed below.</p>
        <list list-type="bullet">
          <list-item>
            <p>Trichostasis spinulosa: usually asymptomatic, dilated hyperkeratotic follicles with several vellus hairs.<xref ref-type="bibr" rid="article-140665.r20">[20]</xref></p>
          </list-item>
          <list-item>
            <p>Follicular hyperkeratotic spicules: predominantly associated with multiple myeloma and located on the face.</p>
          </list-item>
          <list-item>
            <p>Lichen spinulosus: follicular papules, keratin spines, favors trunk and extremities.</p>
          </list-item>
          <list-item>
            <p>Spiky follicular mycosis fungicides: erythematous, hyperkeratotic follicular papules associated with lymphoma.<xref ref-type="bibr" rid="article-140665.r21">[21]</xref></p>
          </list-item>
          <list-item>
            <p>Disseminated spiked hyperkeratosis: small, non-follicular keratin spikes with a genetic association.<xref ref-type="bibr" rid="article-140665.r22">[22]</xref></p>
          </list-item>
          <list-item>
            <p>Ulerythema ophryogenes (keratosis pilaris atrophicans fasciei): erythematous facial papules, scarring alopecia of eyebrows, permanent eyebrow loss.</p>
          </list-item>
          <list-item>
            <p>Follicular-based graft versus host disease: hyperkeratotic, erythematous, folliculocentric papules, occurs post-bone marrow transplant.<xref ref-type="bibr" rid="article-140665.r3">[3]</xref><xref ref-type="bibr" rid="article-140665.r23">[23]</xref></p>
          </list-item>
        </list>
        <p>Other polyomaviruses of the skin:&#x000a0;Seven different species of polyomavirus have been detected in the skin. In addition to TSPyV, Merkel cell polyomavirus (MCPyV) and human polyomaviruses 6, 7, 9, 10, and 13 have been isolated from the skin. However, only MCPyV, HPyV6, and HPyV7 have pathologic associations at this time, particularly in the immunocompromised setting. MCPyV causes Merkel cell carcinoma, classically described as a painless, rapidly growing, reddish-blue nodule. HPVy6 and HPVy7 are associated with pruritic and dyskeratotic dermatosis, described as pruritic, hyperpigmented, lichenified plaques on the torso and extremities. However, case reports are limited such that declaring a &#x0201c;classic&#x0201d; presentation is premature.<xref ref-type="bibr" rid="article-140665.r24">[24]</xref></p>
      </sec>
      <sec id="article-140665.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Although there is no widely accepted treatment regimen for trichodysplasia spinulosa, the prognosis is relatively good, although it may take months to years to fully resolve. In some cases, the condition regresses spontaneously or after the completion of the immunosuppressive treatment. The associated alopecia of the eyebrows and eyelashes and leonine facial disfiguration also resolve over time with the resolution of active disease. The underlying condition that either causes or requires immunosuppression is much more pertinent to the prognosis for the patient as a whole.</p>
      </sec>
      <sec id="article-140665.s12" sec-type="Complications">
        <title>Complications</title>
        <p>Potential complications include pruritus, temporary loss of eyebrows and eyelashes, facial disfiguration, and the associated psychological distress that accompanies these symptoms.</p>
      </sec>
      <sec id="article-140665.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients should be reassured that trichodysplasia spinulosa is benign, and with time, treatment, and, if applicable, completion of immunosuppressive therapy, the skin changes will resolve, and eyebrows will regrow. One specific treatment has not yet been widely accepted; however, topical cidofovir and oral valganciclovir are reasonable options with multiple reports of success.<xref ref-type="bibr" rid="article-140665.r1">[1]</xref></p>
      </sec>
      <sec id="article-140665.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Thankfully, there is no known mortality attributed to trichodysplasia spinulosa, and the morbidity may be primarily cosmetic. Still, it has the potential to cause pruritus, psychological stress associated with its prominently visible symptoms, and psychological stress associated with prognostic uncertainty while patients await a definitive diagnosis and treatment plan. The two known contributing factors for trichodysplasia spinulosa (TSPyV infection and immunosuppression) are not reasonable targets for prevention due to the ubiquitous nature of TSPyV and the implied medical necessity of immunosuppressive therapy in the relevant patient population.<xref ref-type="bibr" rid="article-140665.r1">[1]</xref></p>
        <p>However, other contributing factors yet to be known could theoretically provide an appropriate avenue for prevention. Collaboration between an interprofessional team of dermatologists, immunologists, virologists, and other healthcare specialists in both clinical and academic settings is required to enhance patient-centered care. Clinical recognition and publication of cases of trichodysplasia spinulosa are needed to better understand risk factors and build the repertoire of treatment options. Investigation of the pathophysiology of this condition and mechanisms of proposed treatments is necessary&#x000a0;to clarify and validate their efficacy. Ultimately, expanding upon the paucity of knowledge about trichodysplasia spinulosa will increase diagnostic fidelity, improve patient counseling and reassurance, and firmly establish effective treatment options. [Level 5]</p>
      </sec>
      <sec id="article-140665.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=140665&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=140665">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/skin-problems-and-treatments/trichodysplasia-spinulosa/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=140665">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/140665/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=140665">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-140665.s16">
        <fig id="article-140665.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Histology, Trichodysplasia Spinulosa. The left column shows hematoxylin and eosin staining of healthy skin (A1) and trichodysplasia spinulosa lesional skin (B1) at low power. At high power, healthy (A2) and trichodysplasia spinulosa (B2) epidermis and hair follicles (A3 and B3) are depicted. An enlarged and dysmorphic hair follicle is evident in B3, containing eosinophilic granular protein deposits in the cytoplasm of cells (arrowheads in inset) with abrupt cornification in the follicle center. Bars represent 100 &#x000b5;m. Kazem S, van der Meijden E, Wang RC, et al. Polyomavirus-associated trichodysplasia spinulosa involves hyperproliferation, pRB phosphorylation and upregulation of p16 and p21. <italic toggle="yes">PLoS ONE.</italic> 2014;9(10):e108947. doi: 10.1371/journal.pone.0108947.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Kazem_plosone_2014_TSPyV_histology" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-140665.s17">
        <fig id="article-140665.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Polyomavirus, Electron Microscopy. Icosahedral virions with a "bumpy-like" appearance, approximately&#x000a0;40-45 nm diameter. Erskine Palmer,&#x000a0;MD, via&#x000a0;Public Health Image Library, Public Domain, Centers for Disease Control and Prevention</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="PHIL5629_EM__polyomavirus" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-140665.s18">
        <fig id="article-140665.image.f3" position="float" orientation="portrait">
          <caption>
            <p>A. Leonine facial appearance, eyebrow alopecia, papules on nose, cheeks, chin, forehead and ears. B. Keratotic spicules and papules of nose. C. HE stain at 10x magnification, biopsy from affected forehead skin. Hyperplastic hair bulbs with distended infundibula and hypercornification. D. Nose 3 months post treatment with topical cidofovir treatment. "Clinical appearance and histology of the trichodysplasia spinulosa patient." by Els van der Meijden, Ren&#x000e9; W. A. Janssens, Chris Lauber, Jan Nico Bouwes Bavinck, Alexander E. Gorbalenya, Mariet C. W. Feltkamp from http://journals.plos.org/plospathogens/article? id=10.1371/journal.ppat.1001024. Creative Commons Attribution license 4.0</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Trichodysplasia__Spinulosa" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-140665.s19">
        <title>References</title>
        <ref id="article-140665.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Curman</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>N&#x000e4;sman</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Brauner</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Trichodysplasia spinulosa: a comprehensive review of the disease and its treatment.</article-title>
            <source>J Eur Acad Dermatol Venereol</source>
            <year>2021</year>
            <month>May</month>
            <volume>35</volume>
            <issue>5</issue>
            <fpage>1067</fpage>
            <page-range>1067-1076</page-range>
            <pub-id pub-id-type="pmid">33559344</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140665.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Izakovic</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>B&#x000fc;chner</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>D&#x000fc;ggelin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Guggenheim</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Itin</surname>
                <given-names>PH</given-names>
              </name>
            </person-group>
            <article-title>[Hair-like hyperkeratoses in patients with kidney transplants. A new cyclosporin side-effect].</article-title>
            <source>Hautarzt</source>
            <year>1995</year>
            <month>Dec</month>
            <volume>46</volume>
            <issue>12</issue>
            <fpage>841</fpage>
            <page-range>841-6</page-range>
            <pub-id pub-id-type="pmid">8567267</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140665.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Haycox</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fleckman</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>LT</given-names>
              </name>
              <name>
                <surname>Piepkorn</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sundberg</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Howell</surname>
                <given-names>DN</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>SE</given-names>
              </name>
            </person-group>
            <article-title>Trichodysplasia spinulosa--a newly described folliculocentric viral infection in an immunocompromised host.</article-title>
            <source>J Investig Dermatol Symp Proc</source>
            <year>1999</year>
            <month>Dec</month>
            <volume>4</volume>
            <issue>3</issue>
            <fpage>268</fpage>
            <page-range>268-71</page-range>
            <pub-id pub-id-type="pmid">10674379</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140665.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>van der Meijden</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Janssens</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Lauber</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bouwes Bavinck</surname>
                <given-names>JN</given-names>
              </name>
              <name>
                <surname>Gorbalenya</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Feltkamp</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>Discovery of a new human polyomavirus associated with trichodysplasia spinulosa in an immunocompromized patient.</article-title>
            <source>PLoS Pathog</source>
            <year>2010</year>
            <month>Jul</month>
            <day>29</day>
            <volume>6</volume>
            <issue>7</issue>
            <fpage>e1001024</fpage>
            <pub-id pub-id-type="pmid">20686659</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140665.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kazem</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>van der Meijden</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Feltkamp</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>The trichodysplasia spinulosa-associated polyomavirus: virological background and clinical implications.</article-title>
            <source>APMIS</source>
            <year>2013</year>
            <month>Aug</month>
            <volume>121</volume>
            <issue>8</issue>
            <fpage>770</fpage>
            <page-range>770-82</page-range>
            <pub-id pub-id-type="pmid">23593936</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140665.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dalianis</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hirsch</surname>
                <given-names>HH</given-names>
              </name>
            </person-group>
            <article-title>Human polyomaviruses in disease and cancer.</article-title>
            <source>Virology</source>
            <year>2013</year>
            <month>Mar</month>
            <day>15</day>
            <volume>437</volume>
            <issue>2</issue>
            <fpage>63</fpage>
            <page-range>63-72</page-range>
            <pub-id pub-id-type="pmid">23357733</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140665.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>van der Meijden</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Horv&#x000e1;th</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Nijland</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>de Vries</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>R&#x000e1;cz</surname>
                <given-names>EK</given-names>
              </name>
              <name>
                <surname>Diercks</surname>
                <given-names>GF</given-names>
              </name>
              <name>
                <surname>de Weerd</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Clahsen-van Groningen</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>van der Blij-de Brouwer</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>van der Zon</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Kroes</surname>
                <given-names>ACM</given-names>
              </name>
              <name>
                <surname>Hedman</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>van Kampen</surname>
                <given-names>JJA</given-names>
              </name>
              <name>
                <surname>Riezebos-Brilman</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Feltkamp</surname>
                <given-names>MCW</given-names>
              </name>
            </person-group>
            <article-title>Primary Polyomavirus Infection, Not Reactivation, as the Cause of Trichodysplasia Spinulosa in Immunocompromised Patients.</article-title>
            <source>J Infect Dis</source>
            <year>2017</year>
            <month>Apr</month>
            <day>01</day>
            <volume>215</volume>
            <issue>7</issue>
            <fpage>1080</fpage>
            <page-range>1080-1084</page-range>
            <pub-id pub-id-type="pmid">27578847</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140665.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>van der Meijden</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Bialasiewicz</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rockett</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Tozer</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Sloots</surname>
                <given-names>TP</given-names>
              </name>
              <name>
                <surname>Feltkamp</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>Different serologic behavior of MCPyV, TSPyV, HPyV6, HPyV7 and HPyV9 polyomaviruses found on the skin.</article-title>
            <source>PLoS One</source>
            <year>2013</year>
            <volume>8</volume>
            <issue>11</issue>
            <fpage>e81078</fpage>
            <pub-id pub-id-type="pmid">24278381</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140665.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Richey</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Graham</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Katona</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Travers</surname>
                <given-names>JB</given-names>
              </name>
            </person-group>
            <article-title>Development of trichodysplasia spinulosa: case report of a patient with Gorlin syndrome treated with vismodegib.</article-title>
            <source>JAMA Dermatol</source>
            <year>2014</year>
            <month>Sep</month>
            <volume>150</volume>
            <issue>9</issue>
            <fpage>1016</fpage>
            <page-range>1016-8</page-range>
            <pub-id pub-id-type="pmid">25054782</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140665.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moens</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Krumbholz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ehlers</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Zell</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Johne</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Calvignac-Spencer</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lauber</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Biology, evolution, and medical importance of polyomaviruses: An update.</article-title>
            <source>Infect Genet Evol</source>
            <year>2017</year>
            <month>Oct</month>
            <volume>54</volume>
            <fpage>18</fpage>
            <page-range>18-38</page-range>
            <pub-id pub-id-type="pmid">28634106</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140665.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pedergnana</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Martel-Jantin</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Nicol</surname>
                <given-names>JTJ</given-names>
              </name>
              <name>
                <surname>Leblond</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Tortevoye</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Coursaget</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Touz&#x000e9;</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Abel</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Gessain</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Trichodysplasia Spinulosa Polyomavirus Infection Occurs during Early Childhood with&#x000a0;Intrafamilial Transmission, Especially from Mother to Child.</article-title>
            <source>J Invest Dermatol</source>
            <year>2017</year>
            <month>May</month>
            <volume>137</volume>
            <issue>5</issue>
            <fpage>1181</fpage>
            <page-range>1181-1183</page-range>
            <pub-id pub-id-type="pmid">28108298</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140665.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>van der Meijden</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Kazem</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Burgers</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Janssens</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bouwes Bavinck</surname>
                <given-names>JN</given-names>
              </name>
              <name>
                <surname>de Melker</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Feltkamp</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>Seroprevalence of trichodysplasia spinulosa-associated polyomavirus.</article-title>
            <source>Emerg Infect Dis</source>
            <year>2011</year>
            <month>Aug</month>
            <volume>17</volume>
            <issue>8</issue>
            <fpage>1355</fpage>
            <page-range>1355-63</page-range>
            <pub-id pub-id-type="pmid">21801610</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140665.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Birge</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Boeltz</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Carlson</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wanderley</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Calianese</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Barcinski</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Brekken</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Hutchins</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Freimark</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Empig</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mercer</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Schroit</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Schett</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Herrmann</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancer.</article-title>
            <source>Cell Death Differ</source>
            <year>2016</year>
            <month>Jun</month>
            <volume>23</volume>
            <issue>6</issue>
            <fpage>962</fpage>
            <page-range>962-78</page-range>
            <pub-id pub-id-type="pmid">26915293</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140665.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Helle</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Handala</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bentz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Duverlie</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Brochot</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Intercellular Transmission of Naked Viruses through Extracellular Vesicles: Focus on Polyomaviruses.</article-title>
            <source>Viruses</source>
            <year>2020</year>
            <month>Sep</month>
            <day>26</day>
            <volume>12</volume>
            <issue>10</issue>
            <pub-id pub-id-type="pmid">32993049</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140665.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kazem</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>van der Meijden</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Rosenberg</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Pope</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Benoit</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Fleckman</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Feltkamp</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>Polyomavirus-associated Trichodysplasia spinulosa involves hyperproliferation, pRB phosphorylation and upregulation of p16 and p21.</article-title>
            <source>PLoS One</source>
            <year>2014</year>
            <volume>9</volume>
            <issue>10</issue>
            <fpage>e108947</fpage>
            <pub-id pub-id-type="pmid">25291363</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140665.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Prado</surname>
                <given-names>JCM</given-names>
              </name>
              <name>
                <surname>Monezi</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Amorim</surname>
                <given-names>AT</given-names>
              </name>
              <name>
                <surname>Lino</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Paladino</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Boccardo</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Human polyomaviruses and cancer: an overview.</article-title>
            <source>Clinics (Sao Paulo)</source>
            <year>2018</year>
            <month>Oct</month>
            <day>11</day>
            <volume>73</volume>
            <issue>suppl 1</issue>
            <fpage>e558s</fpage>
            <pub-id pub-id-type="pmid">30328951</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140665.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sperling</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Tomaszewski</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>DA</given-names>
              </name>
            </person-group>
            <article-title>Viral-associated trichodysplasia in patients who are immunocompromised.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2004</year>
            <month>Feb</month>
            <volume>50</volume>
            <issue>2</issue>
            <fpage>318</fpage>
            <page-range>318-22</page-range>
            <pub-id pub-id-type="pmid">14726896</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140665.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schneider</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Schmidt-Ullrich</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Paus</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>The hair follicle as a dynamic miniorgan.</article-title>
            <source>Curr Biol</source>
            <year>2009</year>
            <month>Feb</month>
            <day>10</day>
            <volume>19</volume>
            <issue>3</issue>
            <fpage>R132</fpage>
            <page-range>R132-42</page-range>
            <pub-id pub-id-type="pmid">19211055</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140665.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sridharan</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Shankar</surname>
                <given-names>AA</given-names>
              </name>
            </person-group>
            <article-title>Toluidine blue: A review of its chemistry and clinical utility.</article-title>
            <source>J Oral Maxillofac Pathol</source>
            <year>2012</year>
            <month>May</month>
            <volume>16</volume>
            <issue>2</issue>
            <fpage>251</fpage>
            <page-range>251-5</page-range>
            <pub-id pub-id-type="pmid">22923899</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140665.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kositkuljorn</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Suchonwanit</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Trichostasis Spinulosa: A Case Report with an Unusual Presentation.</article-title>
            <source>Case Rep Dermatol</source>
            <year>2020</year>
            <season>Sep-Dec</season>
            <volume>12</volume>
            <issue>3</issue>
            <fpage>178</fpage>
            <page-range>178-185</page-range>
            <pub-id pub-id-type="pmid">33250734</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140665.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Leerunyakul</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Chirasuthat</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Suchonwanit</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>A Case Report of Idiopathic Follicular Hyperkeratotic Spicules and Literature Review.</article-title>
            <source>Case Rep Dermatol</source>
            <year>2019</year>
            <season>Sep-Dec</season>
            <volume>11</volume>
            <issue>3</issue>
            <fpage>278</fpage>
            <page-range>278-285</page-range>
            <pub-id pub-id-type="pmid">31762741</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140665.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Frenk</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Mevorah</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Leu</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Disseminated spiked hyperkeratosis. An unusual discrete nonfollicular keratinization disorder.</article-title>
            <source>Arch Dermatol</source>
            <year>1981</year>
            <month>Jul</month>
            <volume>117</volume>
            <issue>7</issue>
            <fpage>412</fpage>
            <page-range>412-4</page-range>
            <pub-id pub-id-type="pmid">7259220</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140665.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ho</surname>
                <given-names>YH</given-names>
              </name>
              <name>
                <surname>Chiu</surname>
                <given-names>YW</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>HN</given-names>
              </name>
            </person-group>
            <article-title>Follicular Graft-versus-host Disease: A Rare Manifestation in a Patient with the Overlap Subtype of Chronic Graft-versus-host Disease.</article-title>
            <source>Indian J Dermatol</source>
            <year>2019</year>
            <season>Jul-Aug</season>
            <volume>64</volume>
            <issue>4</issue>
            <fpage>324</fpage>
            <page-range>324-327</page-range>
            <pub-id pub-id-type="pmid">31516145</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140665.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sheu</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Tran</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rady</surname>
                <given-names>PL</given-names>
              </name>
              <name>
                <surname>Dao</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Tyring</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>HP</given-names>
              </name>
            </person-group>
            <article-title>Polyomaviruses of the skin: integrating molecular and clinical advances in an emerging class of viruses.</article-title>
            <source>Br J Dermatol</source>
            <year>2019</year>
            <month>Jun</month>
            <volume>180</volume>
            <issue>6</issue>
            <fpage>1302</fpage>
            <page-range>1302-1311</page-range>
            <pub-id pub-id-type="pmid">30585627</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
